STOCK TITAN

Grifols SA (GIFOF) Stock Price, News & Analysis

GIFOF OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
1 5 sessions, January 29, 2026 to October 21, 2026
Largest daily move
+7.9% close of April 17, 2026

Company Description

Grifols SA (OTC: GIFOF) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $5.0B.

GIFOF gained 3.0% in the week to October 21, 2026. The last closing price was $7.29.

For FY2025, Grifols SA reported revenue of $8.8B with net income of $471.8M and diluted earnings per share of $0.69. The company operates at a net profit margin of 5.3%.

This page collects what Stock Titan holds for GIFOF, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

$7.29
No recent trading
Last close: October 21, 2026
+3%
1 week to October 21, 2026
258.2M
Shares outstanding this listing only

Grifols SA (GIFOF) closed at $7.29 on October 21, 2026. In the week to October 21, 2026, the price gained 3.0%.

See what a $1,000 investment in GIFOF would be worth today

Average down calculator for GIFOF

GIFOF Metrics & Rankings

Market Cap
$5.0B
View ranking

Price returns through October 21, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for GIFOF.

Financial Highlights

Grifols SA generated $8.8B in revenue in FY2025, retaining a 38.0% gross margin, operating income reached $1.5B (16.5% operating margin), and net income was $471.8M, reflecting a 5.3% net profit margin. Diluted earnings per share stood at $0.69. The company generated $1.2B in operating cash flow. The current ratio was 2.51, measuring current assets divided by current liabilities.

$8.8B
Revenue (FY2025)
$471.8M
Net Income (FY2025)
$1.2B
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for GIFOF.

Short Interest History

Last 12 Months

Short interest in Grifols SA (GIFOF) currently stands at 126.7 thousand shares, down 13.1% from the previous reporting period, representing 0.0% of the float. Since November 2025, short interest has increased by 360.9%.

Days to Cover History

Last 12 Months

Days to cover for Grifols SA (GIFOF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

GIFOF Company Profile & Sector Positioning

Grifols SA (GIFOF) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing GIFOF often look at related companies in the same sector, including Ono Pharm Co (OPHLY), Hikma Pharms PLC (HKMPY), Hikma Pharmaceuticals PLC (HKMPF), CSPC Pharms Grp (CSPCY), and Sumitomo Pharma Co (SMDPY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GIFOF's relative position within its industry.

Frequently Asked Questions

Grifols SA (GIFOF) has no recent trading. Its last close was $7.29 on October 21, 2026.

The market cap of Grifols SA (GIFOF) is approximately $5.0B. Learn more about what market capitalization means .

The FY2025 revenue of Grifols SA (GIFOF) is $8.8B, from its most recent completed fiscal year.

The FY2025 net income of Grifols SA (GIFOF) is $471.8M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Grifols SA (GIFOF) is $0.69 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Grifols SA (GIFOF) is $1.2B for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Grifols SA (GIFOF) is 5.3% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Grifols SA (GIFOF) is 16.5% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Grifols SA (GIFOF) is 38.0% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Grifols SA (GIFOF), current assets divided by current liabilities, was 2.51 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Grifols SA (GIFOF) is $3.4B for FY2025, its most recent completed fiscal year.

The operating income of Grifols SA (GIFOF) is $1.5B for FY2025, its most recent completed fiscal year. Learn about operating income.